Cargando…
Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil
Calcineurin inhibitors (CNI), the cornerstone of immunosuppression after transplantation are implicated in nephrotoxicity and allograft dysfunction. We hypothesized that combined low doses of CNI and Everolimus (EVR) may result in better graft outcomes and greater tolerogenic milieu. Forty adult ren...
Autores principales: | Traitanon, Opas, Mathew, James M., Shetty, Aneesha, Bontha, Sai Vineela, Maluf, Daniel G., El Kassis, Yvonne, Park, Sook H., Han, Jing, Ansari, M. Javeed, Leventhal, Joseph R., Mas, Valeria, Gallon, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538151/ https://www.ncbi.nlm.nih.gov/pubmed/31136582 http://dx.doi.org/10.1371/journal.pone.0216300 |
Ejemplares similares
-
Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014) -
Mycophenolate-mofetil/prednisone/tacrolimus: Infections: case report
Publicado: (2020) -
Mycophenolate mofetil/tacrolimus: Cutaneous leishmaniasis: case report
Publicado: (2021) -
Mycophenolate-mofetil/tacrolimus: COVID-19: case report
Publicado: (2022) -
Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
por: Dalal, P, et al.
Publicado: (2010)